Barley CslF6 Mutations for Malting Efficiency

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

The malting process in beer production is time and energy consuming due to the need to reduce (1,3;1,4)-β-glucan levels in barley kernels, but barley plants with low (1,3;1,4)-β-glucans often exhibit reduced agronomic characteristics and grain hardness.

Innovation Solution

Development of barley plants with a mutation in the CslF6 gene, specifically a mutant CslF6 polypeptide with amino acid substitutions in membrane-localized domains, which reduces (1,3;1,4)-β-glucan content while maintaining acceptable agronomic traits and grain hardness, and allows for fine-tuning of the DP3:DP4 ratio.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Loss of time

If barley plants are bred to have low (1,3;1,4)-β-glucan levels to reduce malting time and energy consumption, then malting process efficiency is improved, but grain hardness and agronomic characteristics deteriorate

Engineering Contradiction:
Improvemalting process timeVSAvoidgrain hardness
Core Design Contradiction:
Loss of timeVSStrength

Solution Approach 1:

The patent applies parameter changes by modifying the CslF6 gene to alter the DP3:DP4 ratio of (1,3;1,4)-β-glucans. By changing the molecular structure parameters (degree of polymerization ratio) rather than simply reducing total glucan content, the invention achieves reduced malting time while preserving grain hardness and agronomic traits. The mutant CslF6 enzyme produces glucans with specific DP3:DP4 ratios that are less problematic during malting while maintaining cell wall integrity.

Inventive Principle:
Principle #35Parameter changes

2Object-generated harmful factors

If conventional malting processes are used to reduce (1,3;1,4)-β-glucan levels, then soluble β-glucan content is reduced, but energy consumption and processing time increase

Engineering Contradiction:
Improvesoluble (1,3;1,4)-β-glucan contentVSAvoidmalting energy consumption
Core Design Contradiction:
Object-generated harmful factorsVSUse of energy by stationary object

Solution Approach 1:

The patent applies preliminary action by pre-modifying the barley plants with CslF6 mutations before malting. The plants are genetically prepared to produce (1,3;1,4)-β-glucans with optimized DP3:DP4 ratios that are inherently less problematic during malting. This preliminary genetic modification eliminates the need for extended malting processes designed to degrade glucans, thereby reducing energy consumption and processing time while achieving the desired low soluble β-glucan content.

Inventive Principle:
Principle #10Preliminary action

3Object-generated harmful factors

If barley plants with low (1,3;1,4)-β-glucans are used, then filtration and haze issues are reduced, but yield and agronomic performance decrease

Engineering Contradiction:
Improvebrewing haze and filtration problemsVSAvoidbarley yield
Core Design Contradiction:
Object-generated harmful factorsVSProductivity

Solution Approach 1:

The patent applies local quality by making specific modifications to the CslF6 gene that affect only the DP3:DP4 ratio of (1,3;1,4)-β-glucans while leaving other aspects of plant development and productivity unaffected. The localized genetic modification targets the enzymatic function of CslF6 to produce glucans with specific structural properties that improve brewing characteristics without compromising overall plant yield and agronomic performance.

Inventive Principle:
Principle #3Local quality

Data Source

PatentUS11690341B2Cereal plants with improved cell wall properties
Publication Date: 2023.07.04 CARLSBERG BREWERIES AS
  • US11690341B2 patent drawing
  • US11690341B2 patent drawing
  • US11690341B2 patent drawing

AI summary

The present invention relates to barley plant or a part thereof, wherein the kernels of said barley plant have a reduced (1,3;1,4)-β-glucan content. The barley plant may carry a mutation in the CslF6 gene, wherein said mutated CslF6 gene encodes a mutant CslF6 polypeptide.